tiprankstipranks
Labcorp to Participate in J.P. Morgan Healthcare Conference
Company Announcements

Labcorp to Participate in J.P. Morgan Healthcare Conference

Story Highlights
  • Labcorp executives to join fireside chat at J.P. Morgan Healthcare Conference.
  • Participation underscores Labcorp’s commitment to industry engagement and strategic insights.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Stay Ahead of the Market:

Laboratory Corporation of America Holdings ( (LH) ) has issued an announcement.

Labcorp announced that its executive management team will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. This participation highlights Labcorp’s ongoing engagement with key industry events, signaling its commitment to maintaining a strong presence in the healthcare sector and providing insights into its strategic direction for stakeholders.

More about Laboratory Corporation of America Holdings

Labcorp Holdings Inc. is a global leader in innovative and comprehensive laboratory services, providing diagnostics and drug development capabilities to doctors, hospitals, pharmaceutical companies, researchers, and patients. With over 60,000 employees serving clients in more than 100 countries, Labcorp played a role in over 80% of the new drugs approved by the FDA in 2022 and conducted over 600 million patient tests worldwide.

YTD Price Performance: 2.68%

Average Trading Volume: 595,475

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: $19.6B

Find detailed analytics on LH stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles